A new synthetic Cu(II) compound, [Cu3(p-3-bmb)2Cl4·(CH3OH)2]n, inhibits tumor growth in vivo and in vitro

European Journal of Pharmacology
Ruili LiAidong Wen

Abstract

Copper(II) mixed-ligand complex, [Cu3(p-3-bmb)2Cl4 (CH3OH)2]n (Cu(II) compound), where p-3-bmb=1((2-(pyridine-3-yl)-1H-benzoimidazol-1-yl) methyl)-1Hbenzotriazole, has been recently found to possess potent anti-tumor activities both in vivo and in vitro. In this study, we demonstrated that Cu(II) compound significantly inhibited tumor growth in mice that inoculated with S180 cells. Meanwhile, the viabilities of HeLa and SGC-7901 cells were inhibited by Cu(II) compound with IC50 values in the range of 5-30 μM. Further mechanistic studies revealed that Cu(II) compound treatment induced cell cycle arrested at G1 phase through p53, p21, cyclinD1, cdk4, pRb and E2F1. Cu(II) compound treatment also induced apoptosis of HeLa and SGC-7901 cells which were accompanied with decrease in mitochondrial membrane potential, increase in reactive oxygen species production, release of cytochrome C, cleavage of caspase-9, caspase-3 and poly ADP-ribose polymerase (PARP) as well as activations of bcl-2 and bax. These results indicate that Cu(II) compound has a promising potential to become a novel anti-cancer agent.

References

Oct 3, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C TolisG Giaccone
Mar 7, 2003·American Journal of Physiology. Renal Physiology·Babu J Padanilam
Jun 27, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J ChasleJ-J Michels
Dec 14, 2004·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Mei HuangHanying Sun
Mar 25, 2005·Nature Reviews. Drug Discovery·Dong Wang, Stephen J Lippard
Aug 12, 2005·Molecular Cancer Therapeutics·Chin-Chung WuYang-Chang Wu
Mar 29, 2007·Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine·Francisco Carvallo-ChaigneauFernando Constantino-Casas
Jun 6, 2008·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Chung-Yi ChenChing-Hsein Chen
Apr 4, 2009·Journal of Biomedicine & Biotechnology·Siddig Ibrahim Abdel WahabSyam Mohan
Jul 31, 2009·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·Zhaohui XueWancong Yu
Sep 15, 2009·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Yun-Bin WangLi-Ping Xie
Nov 3, 2009·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Chun-Ying XieXi-Sha Wang
Feb 9, 2010·Journal of Ethnopharmacology·Ho Gyoung KimTae Woong Kim
Sep 21, 2010·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Li Wen GaoJian Wen Wang
Feb 1, 2011·Antioxidants & Redox Signaling·Ute JungwirthPetra Heffeter
May 24, 2011·Toxicology in Vitro : an International Journal Published in Association with BIBRA·J Serment-GuerreroL Ruiz-Azuara
Nov 16, 2011·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Petra Langerak, Paul Russell
Dec 22, 2012·Chemistry Central Journal·Zdeněk TrávníčekZdeněk Dvořák
Jun 14, 2013·Biological Research·Qunwen PanBin Liang

❮ Previous
Next ❯

Citations

Jun 21, 2016·Journal of Inorganic Biochemistry·Spyros PerontsisGeorge Psomas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Cancer Metabolism: Therapeutic Targets

Targeting the mechanisms by which cancer cells acquire energy for metabolic needs is a therapeutic target. Discover the latest research on cancer metabolism and therapeutic targets.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis